Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma. Article

Arrillaga-Romany, Isabel, Kurz, Sylvia Christine, Tarapore, Rohinton et al. (2020). Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma. . JOURNAL OF CLINICAL ONCOLOGY, 38(15_suppl), 3615-3615. 10.1200/jco.2020.38.15_suppl.3615

cited authors

  • Arrillaga-Romany, Isabel; Kurz, Sylvia Christine; Tarapore, Rohinton; Sumrall, Ashley; Butowski, Nicholas A; Harrison, Rebecca A; De Groot, John Frederick; Chi, Andrew S; Shonka, Nicole A; Umemura, Yoshie; Odia, Yazmin; Mehta, Minesh P; Nghiemphu, Phioanh Leia; Cloughesy, Timothy Francis; Lu, Guangrong; Oster, Wolfgang; Allen, Joshua E; Batchelor, Tracy; Lassman, Andrew B; Wen, Patrick Y

authors

publication date

  • May 20, 2020

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.1 Pharmaceuticals
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Neurosciences
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 3615

end page

  • 3615

volume

  • 38

issue

  • 15_suppl